569 related articles for article (PubMed ID: 33417835)
41. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
Elife; 2021 Feb; 10():. PubMed ID: 33570490
[TBL] [Abstract][Full Text] [Related]
42. Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.
Mjokane N; Maliehe M; Folorunso OS; Ogundeji AO; Gcilitshana OMN; Albertyn J; Pohl CH; Sebolai OM
Cells; 2022 Jan; 11(3):. PubMed ID: 35159253
[TBL] [Abstract][Full Text] [Related]
43. Molecular dynamics simulations of the spike trimeric ectodomain of the SARS-CoV-2 Omicron variant: structural relationships with infectivity, evasion to immune system and transmissibility.
de Souza AS; Amorim VMF; de Souza RF; Guzzo CR
J Biomol Struct Dyn; 2023 Nov; 41(19):9326-9343. PubMed ID: 36345794
[TBL] [Abstract][Full Text] [Related]
44. Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2.
Choi KE; Kim JM; Rhee J; Park AK; Kim EJ; Kang NS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445414
[TBL] [Abstract][Full Text] [Related]
45. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
46. The SARS-CoV-2 Spike variant D614G favors an open conformational state.
Mansbach RA; Chakraborty S; Nguyen K; Montefiori DC; Korber B; Gnanakaran S
Sci Adv; 2021 Apr; 7(16):. PubMed ID: 33863729
[TBL] [Abstract][Full Text] [Related]
47. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.
Yan R; Zhang Y; Li Y; Ye F; Guo Y; Xia L; Zhong X; Chi X; Zhou Q
Cell Res; 2021 Jun; 31(6):717-719. PubMed ID: 33737693
[No Abstract] [Full Text] [Related]
48. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works.
Cassari L; Pavan A; Zoia G; Chinellato M; Zeni E; Grinzato A; Rothenberger S; Cendron L; Dettin M; Pasquato A
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902222
[TBL] [Abstract][Full Text] [Related]
50. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
51. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
Song W; Gui M; Wang X; Xiang Y
PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747
[TBL] [Abstract][Full Text] [Related]
52. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
Begum F; Srivastava AK; Tripathi PP; Ray U
J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
[TBL] [Abstract][Full Text] [Related]
53. Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases.
Shokeen K; Pandey S; Shah M; Kumar S
Virus Res; 2022 Sep; 318():198845. PubMed ID: 35680004
[TBL] [Abstract][Full Text] [Related]
54. Cryo-EM structure of the SARS-CoV-2 Omicron spike.
Cerutti G; Guo Y; Liu L; Liu L; Zhang Z; Luo Y; Huang Y; Wang HH; Ho DD; Sheng Z; Shapiro L
Cell Rep; 2022 Mar; 38(9):110428. PubMed ID: 35172173
[TBL] [Abstract][Full Text] [Related]
55. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
[TBL] [Abstract][Full Text] [Related]
56. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Walls AC; Park YJ; Tortorici MA; Wall A; McGuire AT; Veesler D
Cell; 2020 Apr; 181(2):281-292.e6. PubMed ID: 32155444
[TBL] [Abstract][Full Text] [Related]
57. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
Hoffmann M; Kleine-Weber H; Pöhlmann S
Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314
[TBL] [Abstract][Full Text] [Related]
58. Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.
Vankadari N
J Phys Chem Lett; 2020 Aug; 11(16):6655-6663. PubMed ID: 32787225
[TBL] [Abstract][Full Text] [Related]
59. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
Mondal T; Shivange G; Habieb A; Tushir-Singh J
Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
[TBL] [Abstract][Full Text] [Related]
60. Controlling the SARS-CoV-2 spike glycoprotein conformation.
Henderson R; Edwards RJ; Mansouri K; Janowska K; Stalls V; Gobeil SMC; Kopp M; Li D; Parks R; Hsu AL; Borgnia MJ; Haynes BF; Acharya P
Nat Struct Mol Biol; 2020 Oct; 27(10):925-933. PubMed ID: 32699321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
